Posterior reversible leukoencephalopathy syndrome secondary to hepatic transarterial chemoembolization with doxorubicin drug eluting beads.
Posterior reversible encephalopathy syndrome (PRES) is a rare complication of transarterial chemoembolization (TACE) used to treat liver metastases and has never been reported in a patient with metastatic uveal melanoma (UM) to the liver. We report the first case of PRES secondary to TACE with drug eluting beads (DEBs) loaded with doxorubicin in a 56-year-old woman with metastatic UM to the liver.
1 Department of Internal Medicine, 2 Department of Neurology, 3 Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
C Andrew
CA
Kistler
1 Department of Internal Medicine, 2 Department of Neurology, 3 Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Joseph Caleb
JC
McCall
1 Department of Internal Medicine, 2 Department of Neurology, 3 Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Saad Sultan
SS
Ghumman
1 Department of Internal Medicine, 2 Department of Neurology, 3 Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Ijlal Akbar
IA
Ali
1 Department of Internal Medicine, 2 Department of Neurology, 3 Department of Medicine, Division of Gastroenterology and Hepatology, Thomas Jefferson University Hospital, Philadelphia, PA, USA.
Ali A
AA
Siddiqui
Posterior leukoencephalopathy; chemoembolization, therapeutic; doxorubicin; drug-eluting stents; syndrome